Apellis Pharmaceuticals (APLS) PT Lowered to $78 at Raymond James Following Sobi Deal
Tweet Send to a Friend
Raymond James analyst Steven Seedhouse lowered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
